Document
IPR2016-01332, No. 1041 Exhibit - Cancerorg (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1041 Exhibit - Cancerorg (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1031 Exhibit - Tannock 1989 (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1031 Exhibit - Tannock 1989 (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 2163-213 Exhibit - JSN 2163 Sonino, NEJM, 21713812 818 1987 (P.T.A.B. May. 3, 2017)
Cite Document
IPR2016-01332, No. 2163-213 Exhibit - JSN 2163 Sonino, NEJM, 21713812 818 1987 (P.T.A.B. May. 3, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1002 Exhibit - Garnick Declaration (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1002 Exhibit - Garnick Declaration (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1092-160 Exhibit - Hormone Therapy for Prostate Cancer cancerorg (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01332, No. 1092-160 Exhibit - Hormone Therapy for Prostate Cancer cancerorg (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2011-38 Exhibit - JSN 2011 Part 1 Garnick Deposition Ex 3 ¿¿¿ Blackhard, Letter to Editor, J Urology, 14661621 1622 1991 (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2011-38 Exhibit - JSN 2011 Part 1 Garnick Deposition Ex 3 ¿¿¿ Blackhard, Letter to Editor, J Urology, 14661621 1622 1991 (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2031-37 Exhibit - JSN 2031 Burgess and Roth, ¿¿¿Changing Perspectives of the Role of Chemotherapy in Advanced Prostate Cancer,¿¿¿ (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2031-37 Exhibit - JSN 2031 Burgess and Roth, ¿¿¿Changing Perspectives of the Role of Chemotherapy in Advanced Prostate Cancer,¿¿¿ (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2083-90 Exhibit - JSN 2083 Novacea Form 8 K at 102 (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2083-90 Exhibit - JSN 2083 Novacea Form 8 K at 102 (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1016 Exhibit - June 2, 2014 Notice of Allowance (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1016 Exhibit - June 2, 2014 Notice of Allowance (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1071 Exhibit - Oct 3, 2013 IDS (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1071 Exhibit - Oct 3, 2013 IDS (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1054 Exhibit - Murphy (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1054 Exhibit - Murphy (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1145-209 Exhibit - Redacted Hofmann Reply Declaration (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01332, No. 1145-209 Exhibit - Redacted Hofmann Reply Declaration (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2089-96 Exhibit - JSN 2089 NCI SEER Stat Fact Sheets Prostate Cancer (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2089-96 Exhibit - JSN 2089 NCI SEER Stat Fact Sheets Prostate Cancer (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2015-21 Exhibit - JSN 2015 Attard et al, ¿¿¿Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2015-21 Exhibit - JSN 2015 Attard et al, ¿¿¿Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2051-58 Exhibit - JSN 2051 Dorin et al, ¿¿¿Diagnosis of Adrenal Insufficiency,¿¿¿ Ann Inern Med, 139194 204 2003 (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2051-58 Exhibit - JSN 2051 Dorin et al, ¿¿¿Diagnosis of Adrenal Insufficiency,¿¿¿ Ann Inern Med, 139194 204 2003 (P.T.A.B. Mar. 8, 2017)
+ More Snippets